Obicetrapib Clinical Data - ROSE2
Obicetrapib Clinical Data - ROSE2
Obicetrapib Clinical Data - ROSE2

Presentation begins with a top-level introduction of obicetrapib and then details the results of the ROSE2 trial.

Download Now!
Last Modified:
2024-09-19
Obicetrapib
Trial
CETP
Download Now!
Obicetrapib Clinical Data - ROSE
Obicetrapib Clinical Data - ROSE
Obicetrapib Clinical Data - ROSE

Presentation begins with a top-level introduction of obicetrapib and then details the results of the ROSE trial.

Download Now!
Last Modified:
2024-09-13
Obicetrapib
Trial
CETP
Download Now!
Obicetrapib Clinical Development Program
Obicetrapib Clinical Development Program
Obicetrapib Clinical Development Program

Presentation reviews the clinical development program for obicetrapib with a focus on study designs.

Download Now!
Last Modified:
2024-08-23
ASCVD Risk
Unmet Need
Treatment
Download Now!
ASCVD Risk and Elevated LDL-C - Current State of Affairs
ASCVD Risk and Elevated LDL-C - Current State of Affairs
ASCVD Risk and Elevated LDL-C - Current State of Affairs

Presentation educates on the causal relationship between LDL and ASCVD and the sub-optimal state of LDL-C-lowering.

Download Now!
Last Modified:
2024-04-03
Obicetrapib
Trial
ASCVD Risk
Download Now!
Obicetrapib Clinical Data – Japan Ph2
Obicetrapib Clinical Data – Japan Ph2
Obicetrapib Clinical Data – Japan Ph2

Download Now
Last Modified:
2024-08-01
Obicetrapib
Trial
CETP
Download Now
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

View Publication
Last Modified:
2023-12-22
Publication
Obicetrapib
Review
View Publication
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

View Publication
Last Modified:
2014-03-17
Publication
Review
PK
View Publication
Cholesteryl ester transfer protein inhibitors: From high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
Cholesteryl ester transfer protein inhibitors: From high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
Cholesteryl ester transfer protein inhibitors: From high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?

View Publication
Last Modified:
2021-11-20
Publication
Review
CETP Inhibition
View Publication
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: A randomized phase 2 trial (ROSE)
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: A randomized phase 2 trial (ROSE)
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: A randomized phase 2 trial (ROSE)

View Publication
Last Modified:
2022-08-11
Publication
Obicetrapib
Trial
View Publication
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial (ROSE2)
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial (ROSE2)
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial (ROSE2)

View Publication
Last Modified:
2023-05-20
Publication
Obicetrapib
Trial
View Publication
The Evolving Role of Cholesteryl Ester Transfer Protein Inhibition Beyond Cardiovascular Disease
The Evolving Role of Cholesteryl Ester Transfer Protein Inhibition Beyond Cardiovascular Disease
The Evolving Role of Cholesteryl Ester Transfer Protein Inhibition Beyond Cardiovascular Disease

B

View Publication
Last Modified:
2023-10-28
Publication
Review
CETP Inhibition
View Publication